EN DE
Watch Chemfab Alkalis Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Chemfab Alkalis Limited (CHEMFAB) fair value: what the stock is really worth

As of Nov 11, 2026: fair value (intrinsic value) of Chemfab Alkalis Limited stock ₹205, price ₹311, that is 34.0% below the price, quality 36 out of 100. Rating: overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE783X01023

CA Chemfab Alkalis Limited logo Thin data Nov 12, 2026

Chemfab Alkalis Limited

CHEMFAB · NSE
Expensive, weak quality

Our calculation puts a fair price 34% below what the stock costs today.

Low debt
0.4% dividend yield · Token dividend
Fair value ₹205.02 · Overvalued
Quality 36/100
Weak Growth (revenue 3y −2.1 %/yr in INR)
Loss-making · -0.1% net margin (TTM)
Negative free cash flow
Trails peers (1/12)
Narrow moat 23/100
Thin data
⟳ Cyclical⚠ Small free float
Watch Chemfab Alkalis Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹1,177 ₹134.00 Fair Value ₹205.02 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.

How to read this chart

60‑month range ₹134.00 – ₹1,177 · fair‑value band ₹110.34 – ₹299.70 · the ₹310.75 price screens above the ₹205.02 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 12, 2026.

Follow Chemfab Alkalis in your weekly email

Every Wednesday you see whether Chemfab Alkalis is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Chemfab Alkalis Limited, together with its subsidiary, Chemfab Alkalis Karaikal Limited, manufactures and sells inorganic chemicals in India and internationally. The company operates through Chemicals and Related Products/Services; and PVC-O Pipes segments.

Show moreShow less

The company offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor products; sodium chlorate; and alkali, acids, bases, solvents, alcohols, gases, ethers, aliphatics, aromatics, aldehydes ketones, amines, alkaloids, potassium chlorate, perchlorate, and other chemicals, as well as its by-products and derivatives.

It also provides industrial grade and edible salt products; and PVCO pipes. The company was formerly known as Teamec Chlorates Limited and changed its name to Chemfab Alkalis Limited in July 2017. Chemfab Alkalis Limited was founded in 1985 and is based in Chennai, India.

Stock analysis

Chemfab Alkalis Limited (CHEMFAB) currently trades at ₹310.75, while our model-based Fair Value estimate is ₹205.02, 34% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: ₹110.34 (bear) to ₹299.70 (bull), the price of ₹310.75 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 36/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Chemfab Alkalis Limited reported revenue of ₹3.1B in FY2026 versus ₹2.7B in FY2022, a compound +3.5%/yr. Reported net income was −₹34.3M in FY2026.

Key figures

Market cap ₹4.5B (≈ $47.7M) Micro · P/S ratio 1.48 · EPS (TTM) ₹−0.1600 · Dividend yield 0.4% · Net margin −0.1% · Return on equity −0.1% · Return on assets (EBIT) 10.9% (5-year average) · Operating margin −0.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (medium confidence).

What moves the price

The share trades about 42% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −42% fair-value upside, at −34%, CHEMFAB screens cheaper than that median.

Fair Value models

Bear ₹110.34 Fair Value ₹205.02 Bull ₹299.70
Price ₹310.75 · Downside -34.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA ₹55.17 ₹102.51 ₹149.85 65
NCAV (Graham) ₹130.38 ₹174.71 ₹260.77 54
All 2 models by family
Multiples
EV/EBITDA ₹55.17 ₹102.51 ₹149.85 65
Asset-Based
NCAV (Graham) ₹130.38 ₹174.71 ₹260.77 54

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 36/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 17
How much profit the company makes from its sales and capital
Quality Growth 18
Are margins and returns getting better?
Cashflow 14
Do the profits arrive as real cash?
Financial strength 56
Debt, balance sheet and risk of trouble
Investment 45
Does it invest with discipline instead of growing at any price?
Low Volatility 71
How calm the share price moves, does not count
Price momentum 11
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 4
Distance to the 52-week high, does not count
New shares 78
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 26/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−7.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.5%
Start year 2021 (pandemic). Over 10 years: +11.9% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
5.2% (2021) → −0.4% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

CHEMFAB screens overvalued: fair value 34% below the price. Compare with Linde plc →

Compare Chemfab Alkalis Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 753 stocks

Beats the industry median on 1/11 measures
Overall it trails its industry peers.
Valuation
Quality Score 36 · Bottom 25%
Fair Value upside −34.0% · Below median
Profitability
Return on assets −0.6% · Bottom 25%
Net margin (12 months) −0.1% · Bottom 25%
Operating margin (12 months) −0.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −0.7% · Bottom 25%
Dividend yield (12 months) 0.4% · Bottom 25%
Balance sheet
Debt / equity 0.22× · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 1.19× · Cheaper than median
P/S (12 months) 1.54× · Pricier than median
EV/EBITDA 19.9× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 3
FUTURE (revenue growth)0 · sector 67
PAST (return on equity)0 · sector 25
HEALTH (low debt)89 · sector 95
DIVIDEND (yield)8 · sector 30

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥69.90 ¥68.03 −3% vs CHEMFAB
Linde plc LIN $526.55 $446.62 −15% vs CHEMFAB
PPG Industries, Inc PPG $124.97 $77.68 −38% vs CHEMFAB
DSM-Firmenich AG DSFIR CHF 98.20 CHF 57.84 −41% vs CHEMFAB
Asian Paints Limited ASIANPAINT ₹2,550 ₹1,479 −42% vs CHEMFAB
The Sherwin-Williams Company SHW $355.76 $152.59 −57% vs CHEMFAB
Givaudan SA GIVN CHF 4,084 CHF 1,629 −60% vs CHEMFAB
EMS-CHEMIE HOLDING AG EMSN CHF 846.00 CHF 284.63 −66% vs CHEMFAB
Ecolab Inc ECL $307.86 $97.18 −68% vs CHEMFAB
Air Products and Chemicals, Inc APD $315.18 $75.33 −76% vs CHEMFAB

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Chemfab Alkalis Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Chemfab Alkalis Limited Fair Value". https://www.fairvalue-calculator.com/stock/CHEMFAB

Frequently asked questions

Is Chemfab Alkalis Limited (CHEMFAB) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of ₹205.02 versus a price of ₹310.75, about 34% lower (overvalued).
What is the fair value of CHEMFAB?
Our model-based fair value for Chemfab Alkalis Limited is ₹205.02 (as of Nov 12, 2026), built from audited fundamentals. The current price: ₹310.75.
What is the quality score of CHEMFAB?
Chemfab Alkalis Limited has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Chemfab Alkalis Limited (CHEMFAB)?
Our model-based price target is the fair value of ₹205.02 (as of Nov 12, 2026) from 2 valuation models. Cautious scenario ₹110.34, optimistic scenario ₹299.70. It is a calculation from audited fundamentals, not an analyst target.
What is the Chemfab Alkalis Limited stock forecast for 2026?
Our models put fair value at ₹205.02, about 34% lower versus a price of ₹310.75 (overvalued). Cautious scenario ₹110.34, optimistic scenario ₹299.70. The calculation is refreshed regularly with new filings.
What is the revenue of Chemfab Alkalis Limited (CHEMFAB)?
Chemfab Alkalis Limited reported trailing-twelve-month revenue of about ₹2.9B (latest available figure, as of Nov 12, 2026).
Does Chemfab Alkalis Limited pay a dividend?
Chemfab Alkalis Limited currently shows a dividend yield of 0.40% relative to its recent price (as of Nov 12, 2026).
How much is the dividend of Chemfab Alkalis Limited (CHEMFAB) and when is the ex-dividend date?
Chemfab Alkalis Limited pays a dividend of ₹1.25 per share a year, a dividend yield of 0.4%. The last ex-dividend date was Sep 2, 2026. A dividend has been paid every year since 2022. Our assessment: Token dividend. At a yield of 0.4% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.4% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Chemfab Alkalis Limited (CHEMFAB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Chemfab Alkalis Limited it is ₹205.02 per share (as of Nov 12, 2026), against a price of ₹310.75. It is the blended result of 2 valuation models in 2 families (Multiples, Asset-Based).
Is Chemfab Alkalis Limited stock overvalued or undervalued in 2026?
As of Nov 12, 2026, CHEMFAB trades above its calculated fair value: price ₹310.75, fair value ₹205.02, a gap of about −34% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CHEMFAB?
No. The price is what the market pays today (₹310.75); the fair value is what the company's own numbers justify (₹205.02). For Chemfab Alkalis Limited the two are ₹105.73 per share apart. That gap is exactly why we show both numbers side by side.
How much is Chemfab Alkalis Limited worth?
The market values Chemfab Alkalis Limited at about ₹4.5B (market capitalisation, as of Nov 12, 2026). Per share that is ₹310.75; our models calculate a fair value of ₹205.02 per share.
What do the bullish and bearish scenarios say about CHEMFAB?
Our models span a range for Chemfab Alkalis Limited: cautious scenario ₹110.34, base ₹205.02, optimistic ₹299.70 per share (as of Nov 12, 2026, price ₹310.75). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Chemfab Alkalis Limited (CHEMFAB)?
Balance-sheet figures for Chemfab Alkalis Limited (as of Nov 12, 2026): return on equity −0.1%, debt of 0.22 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is CHEMFAB from its 52-week high?
Chemfab Alkalis Limited trades at ₹310.75, about 42% below its 52-week high of ₹534.20 and 7% above the low of ₹291.35 (as of Nov 11, 2026). Distance from the high says nothing about value: that is what the fair value of ₹205.02 is for.
Which stocks are comparable to Chemfab Alkalis Limited?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Chemfab Alkalis Limited stock attractive at the current price?
The data as of Nov 12, 2026: price ₹310.75, calculated fair value ₹205.02 (−34%), Quality Score 36/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CHEMFAB calculated?
We run Chemfab Alkalis Limited through 2 models from 2 families: Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of ₹205.02 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0% above its aggregate fair value. Chemfab Alkalis Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Chemfab Alkalis Limited (CHEMFAB)?
The closing price on Nov 11, 2026 was ₹310.75. Our model-based fair value is ₹205.02, about 34% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Chemfab Alkalis Limited right now?
The price sits above even our optimistic bull case (₹299.70). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (₹110.34 to ₹299.70). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Chemfab Alkalis Limited

How large is the market capitalisation of Chemfab Alkalis Limited (CHEMFAB)?
The market capitalisation of Chemfab Alkalis Limited is ₹4.5B (≈ $47.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Chemfab Alkalis Limited (CHEMFAB)?
The price-to-sales ratio of Chemfab Alkalis Limited is 1.48 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Chemfab Alkalis Limited (CHEMFAB)?
Earnings per share at Chemfab Alkalis Limited are ₹−0.1600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Chemfab Alkalis Limited (CHEMFAB)?
The dividend yield of Chemfab Alkalis Limited is 0.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Chemfab Alkalis Limited (CHEMFAB)?
The net margin of Chemfab Alkalis Limited is −0.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Chemfab Alkalis Limited (CHEMFAB)?
The return on equity (ROE) of Chemfab Alkalis Limited is −0.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Chemfab Alkalis Limited (CHEMFAB)?
On an EBIT basis the return on assets of Chemfab Alkalis Limited is 10.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Chemfab Alkalis Limited (CHEMFAB)?
The operating margin of Chemfab Alkalis Limited is −0.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Chemfab Alkalis Limited (CHEMFAB)?
Revenue at Chemfab Alkalis Limited is growing −0.7% versus a year earlier (3y avg −2.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Chemfab Alkalis Limited (CHEMFAB)?
Earnings per share at Chemfab Alkalis Limited are growing +125% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Chemfab Alkalis Limited (CHEMFAB) generate?
The free cash flow of Chemfab Alkalis Limited is −₹604M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Chemfab Alkalis Limited (CHEMFAB) carry?
The net debt of Chemfab Alkalis Limited is ₹1.2B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Chemfab Alkalis Limited in the live analysis

One click puts Chemfab Alkalis Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.